← Evidence map

ArticleFrontiers in oncology2022

miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer.

Sujin Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36059697